Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00098892%3A_____%2F16%3AN0000002" target="_blank" >RIV/00098892:_____/16:N0000002 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14110/16:00090556 RIV/61989592:15110/16:33154754 RIV/00179906:_____/16:10332813
Result on the web
<a href="http://www.karger.com/Article/FullText/441296" target="_blank" >http://www.karger.com/Article/FullText/441296</a>
DOI - Digital Object Identifier
—

Result language
angličtina
Original language name
Clinical Potential of Effective Noninvasive Exclusion of KEL1-Positive Fetuses in KEL1-Negative Pregnant Women
Original language description
In pregnant women diagnosed with blood cell alloantibody anti-K (K-negative, genotype KEL2/KEL2), the fetuses are at risk of hemolytic disease only if antigen ´K´´(´K´-positive, genotype KEL1/KEL2) is present on their erythrocytes. In reality, however, approximately 95 % of fetuses are ´K´-negative (genotype KEL2/KEL2) and this are not at risk of hemolytic disease . The clinical importance of assessing the fetal KEL genotype is to exclude ´K´-negative fetuses (genotype KEL2/KEL2) in ´K´-negative pregnant women. Maternal anti-K antibodies that penetrate through the placenta during incompatible pregnancy cause suppression of erythropoiesis
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
EC - Immunology
OECD FORD branch
—

Project
<a href="/en/project/NT12225" target="_blank" >NT12225: Determining fetal RHD and KELL genotype from peripheral blood of pregnant women</a><br>
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)